Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Revisiting the Impact of Immunoglobulin Isotypes in Multiple Myeloma

Susan Bal, MDMBBS, Smith Giri, MBBS, Kelly N. Godby, MD, Luciano J. Costa, MD PhD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-138903

Published: 2020

Journal Articles

Redefining the Prognostic Significance of t(11;14) Multiple Myeloma

Susan Bal, MDMBBS, Smith Giri, MBBS, Kelly N. Godby, MD, Luciano J. Costa, MD PhD

Blood (2020) 136 (Supplement 1): 43.

https://doi.org/10.1182/blood-2020-138888

Published: 2020

Journal Articles

Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United States

Amer M. Zeidan, MBBS, MHS, Rong Wang, PhD, Xiaoyi Wang, MD MPH, Rory M Shallis, MD, Nikolai A. Podoltsev, MD PhD, Jan Philipp Bewersdorf, MD, Scott F. Huntington, MD MPH, Natalia Neparidze, MD, Smith Giri, MBBS, MHS, Steven D. Gore, MD, Amy J Davidoff, PhD MS, Xiaomei Ma, PhD

Blood (2019) 134 (Supplement_1): 646.

https://doi.org/10.1182/blood-2019-127398

Published: 2019

Journal Articles

Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study

Amer M. Zeidan, MBBS, MHS, Nikolai A. Podoltsev, MD PhD, Xiaoyi Wang, MD MPH, Jan Philipp Bewersdorf, MD, Rory M Shallis, MD, Scott F. Huntington, MD MPH, Natalia Neparidze, MD, Smith Giri, MBBS, MHS, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J Davidoff, PhD MS, Rong Wang, PhD

Blood (2019) 134 (Supplement_1): 116.

https://doi.org/10.1182/blood-2019-126643

Published: 2019

Journal Articles

Copper Deficiency and Cytopenia: A Systematic Review

Prakash Kharel, MD, Karthik Gnanapandithan, MD MS, Ramesh Kumar Pandey, MD, Samir Jha, Alyssa Grimshaw, MSLIS, Smith Giri, MBBS

Blood (2019) 134 (Supplement_1): 5025.

https://doi.org/10.1182/blood-2019-132265

Published: 2019

Journal Articles

Comparative Effectiveness of Lenalidomide, Bortezomib, and Their Combinations As First-Line Treatment of Older Patients with Myeloma

Peter Barth, MD, Smith Giri, MBBS, John L. Reagan, MD, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 3155.

https://doi.org/10.1182/blood-2019-121992

Published: 2019

Journal Articles

Second Primary Malignancy Among Patients with Plasma Cell Myeloma Receiving First-Line Lenalidomide-Based Therapy: A Population-Based Analysis

Smith Giri, MBBS, Peter Barth, MD, Luciano J. Costa, MD PhD, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 1862.

https://doi.org/10.1182/blood-2019-131231

Published: 2019

Journal Articles

Evaluation of Efficacy and Safety of Front-Line Regimens for the Treatment of Transplant Ineligible Patients with Multiple Myeloma: A Network Meta-Analysis of Phase 2/3 Randomized Controlled Trials

Smith Giri, MBBS, Madan R Aryal, MD, Han Yu, PhD, Alyssa Grimshaw, MSLIS, Ranjan Pathak, MD, Scott F. Huntington, MD MPH, Binod Dhakal, MBBS

Blood (2019) 134 (Supplement_1): 2188.

https://doi.org/10.1182/blood-2019-130389

Published: 2019

Journal Articles

Hematologic Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Systematic Review of Case-Reports and Case-Series

Karthik Gnanapandithan, MD MS, Prakash Kharel, MD, Alyssa Grimshaw, MSLIS, Smith Giri, MBBS

Blood (2019) 134 (Supplement_1): 3606.

https://doi.org/10.1182/blood-2019-132203

Published: 2019

Journal Articles

Transfusion Independence in Lower-Risk, Non-del5(q) Myelodysplastic Syndromes (LR-MDS) Among Patients (pts) Initiating Hypomethylating Agents (HMAs) While Receiving Red Blood Cell (RBC) Transfusions

Amer M. Zeidan, MBBS, MHS, Weiwei Zhu, MPH, Rong Wang, PhD, Maximilian Stahl, MD, Scott F Huntington, MDMPH, Smith Giri, MBBS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Amy J. Davidoff, PhD MS

Blood (2018) 132 (Supplement 1): 838.

https://doi.org/10.1182/blood-2018-99-116497

Published: 2018

Journal Articles

Association between Transplant Volumes and 30-Day Readmissions Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in the US

Binod Dhakal, MBBS, Smith Giri, MBBS, Adam Levin, MD, Rein Lisa, Timothy S. Fenske, MD, Saurabh Chhabra, MD, Nirav N Shah, MD, Aniko Szabo, PhD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD, Mehdi Hamadani, MD

Blood (2018) 132 (Supplement 1): 617.

https://doi.org/10.1182/blood-2018-99-116196

Published: 2018

Journal Articles

Does Provider Experience Treating Patients (pts) with Myelodysplastic Syndromes (MDS) Explain Duration of Hypomethylating Agent (HMA) Therapy and Overall Survival (OS)? A Large Population-Based Analysis

Amer M. Zeidan, MBBS, MHS, Xin Hu, MS, Weiwei Zhu, MPH, Maximilian Stahl, MD, Smith Giri, MBBS, Scott F Huntington, MDMPH, Rong Wang, PhD, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Amy J. Davidoff, PhD MS

Blood (2018) 132 (Supplement 1): 370.

https://doi.org/10.1182/blood-2018-99-111052

Published: 2018

Journal Articles

Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United States

Smith Giri, MBBS, Weiwei Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD MS, Scott F Huntington, MDMPH

Blood (2018) 132 (Supplement 1): 978.

https://doi.org/10.1182/blood-2018-99-119791

Published: 2018

Journal Articles

Incidence and Predictors of 30-Day Readmissions Following Autologous Hematopoietic Cell Transplantation (auto-HCT) in the US

Blood (2018) 132 (Supplement 1): 3544.

https://doi.org/10.1182/blood-2018-99-118873

Published: 2018

Journal Articles

Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility

Scott F Huntington, MD MPH, Weiwei Zhu, MPH, Jessica Hoag, PhD, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Smith Giri, MBBS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Cary P Gross, MD, Amy J. Davidoff, PhD MS

Blood (2018) 132 (Supplement 1): 3538.

https://doi.org/10.1182/blood-2018-99-115140

Published: 2018

Journal Articles

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Polycythemia Vera: A Population-Based Study

Nikolai Podoltsev, MD PhD, Mengxin Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Xiaoyi Wang, MD MPH, Amy J. Davidoff, PhD MS, Scott F Huntington, MD MPH, Smith Giri, MBBS, Steven D. Gore, MD, Xiaomei Ma, PhD

Blood (2018) 132 (Supplement 1): 3580.

https://doi.org/10.1182/blood-2018-99-119272

Published: 2018

Journal Articles

Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma

Smith Giri, MBBS, Ellice Y. Wong, MD, Michal Rose, MD, Roxanne Wadia, MD, Lesley S. Park, PhD MPH, Amy C. Justice, MD PhD, Natalia Neparidze, MD

Blood (2018) 132 (Supplement 1): 3162.

https://doi.org/10.1182/blood-2018-99-115633

Published: 2018

Journal Articles

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

Nikolai Podoltsev, MD PhD, Mengxin Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Xiaoyi Wang, MD MPH, Scott F Huntington, MD MPH, Smith Giri, MBBS, Amy J. Davidoff, PhD MS, Steven D. Gore, MD, Xiaomei Ma, PhD

Blood (2018) 132 (Supplement 1): 4865.

https://doi.org/10.1182/blood-2018-99-119118

Published: 2018

Journal Articles

The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Polycythemia Vera

Nikolai A. Podoltsev, MD PhD, Mengxin Zhu, MPH, Amer M. Zeidan, MD, Rong Wang, PhD, Amy J. Davidoff, PhD MS, Scott Huntington, MDMPH, Smith Giri, MBBS, Steven D. Gore, MD, Xiaomei Ma, MD PhD

Blood (2017) 130 (Supplement 1): 354.

https://doi.org/10.1182/blood.V130.Suppl_1.354.354

Published: 2017

Journal Articles

The Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Essential Thrombocythemia

Nikolai A. Podoltsev, MD PhD, Mengxin Zhu, MPH, Amer M. Zeidan, MD, Rong Wang, PhD, Amy J. Davidoff, PhD MS, Smith Giri, MBBS, Scott Huntington, MDMPH, Steven D. Gore, MD, Xiaomei Ma, MD PhD

Blood (2017) 130 (Supplement 1): 351.

https://doi.org/10.1182/blood.V130.Suppl_1.351.351

Published: 2017

NARROW

Revisiting the Impact of Immunoglobulin Isotypes in Multiple Myeloma

Redefining the Prognostic Significance of t(11;14) Multiple Myeloma

Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United States

Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study

Copper Deficiency and Cytopenia: A Systematic Review

Comparative Effectiveness of Lenalidomide, Bortezomib, and Their Combinations As First-Line Treatment of Older Patients with Myeloma

Second Primary Malignancy Among Patients with Plasma Cell Myeloma Receiving First-Line Lenalidomide-Based Therapy: A Population-Based Analysis

Evaluation of Efficacy and Safety of Front-Line Regimens for the Treatment of Transplant Ineligible Patients with Multiple Myeloma: A Network Meta-Analysis of Phase 2/3 Randomized Controlled Trials

Hematologic Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Systematic Review of Case-Reports and Case-Series

Transfusion Independence in Lower-Risk, Non-del5(q) Myelodysplastic Syndromes (LR-MDS) Among Patients (pts) Initiating Hypomethylating Agents (HMAs) While Receiving Red Blood Cell (RBC) Transfusions

Association between Transplant Volumes and 30-Day Readmissions Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in the US

Does Provider Experience Treating Patients (pts) with Myelodysplastic Syndromes (MDS) Explain Duration of Hypomethylating Agent (HMA) Therapy and Overall Survival (OS)? A Large Population-Based Analysis

Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United States

Incidence and Predictors of 30-Day Readmissions Following Autologous Hematopoietic Cell Transplantation (auto-HCT) in the US

Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Polycythemia Vera: A Population-Based Study

Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Polycythemia Vera

The Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Essential Thrombocythemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only